The October 2023 Drug Tariff has been updated to include a deadline for submission of any outstanding referred back prescriptions to the NHS Business Services Authority (NHSBSA) for payment. All prescriptions that have been referred-back must be completed and returned to the NHSBSA no later than 18 months from the date they are first sent
Read moreThe Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item
Read moreA disallowed item is one that has NOT been passed for payment by the NHS Business Services Authority (NHSBSA). Please check your disallowed items history on Manage Your Service (MYS) portal to identify the list of unpaid items and reasons why the item was disallowed by the NHSBSA. If you believe an item has been
Read moreA new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 2 September 2023) has been published and includes articles on: Statins: very infrequent reports of myasthenia gravis Fluoroquinolone antibiotics: suicidal thoughts and behaviour Letters and medicine recalls sent to healthcare professionals in August 2023. To see the latest MHRA Drug
Read moreThe Drug Tariff Category M pricelist for October 2023 has been published on the NHS Business Services Authority (NHSBSA) website. At the end of Q4 2022/23 there remains an over delivery of medicine margin. The October Category M pricelist includes: Adjustments for underlying market price movements in the reference period April-June 2023. Of particular note is
Read morePharmacy press As today marks World Pharmacists Day, an annual awareness day led by the International Pharmaceutical Federation (FIP) – we, at Community Pharmacy England, celebrating the crucial role pharmacists play in improving access to healthcare, ensuring the responsible use of medicines and so much more. This year’s theme, ‘Pharmacy strengthening health systems’, highlights the
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Hyoscine hydrobromide (Scopoderm®) 1.5mg patches. MSN/2023/087 Tier 2 – medium impact Date of issue 21st September 2023 Hyoscine hydrobromide (Scopoderm®) 1.5mg patches are in limited supply until w/c 1st January 2024. Alternative formulations of hyoscine hydrobromide remain available and will be
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for the Somatropin (Genotropin® MiniQuick) 1.4mg, 1.6mg and 1.8mg powder and solvent for solution for injection pre-filled disposable devices. MSN/2023/089 Tier 2 – medium impact Date of issue 21st September 2023 Somatropin (Genotropin® MiniQuick) 1.4mg, 1.6mg and 1.8mg powder and solvent for
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for the Discontinuation of lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices MSN/2023/088 Tier 2 – medium impact Date of issue 21st September 2023 Lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices are being discontinued and stock will
Read moreDrug alert number: EL (23)A/36 Date issued: 20 September 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Trimbow 87/5/9 mcg pressurised inhalation solution PLGB 08829/0193 SNOMED Code: 34681611000001100 Batch Number Expiry Date Pack Size First Distributed 1165031 18/09/2024 1 container with 120 actuations 19/01/2023 1150215 25/12/2023
Read more
